Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Clotrimazole, an antifungal cream, may safely reduce skin pigmentation by breaking down the enzyme needed for making melanin.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Clofazimine may be effective for treating ashy dermatosis.

Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Biological therapy boosts the immune system to effectively fight melanoma.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Erlotinib can cause hair loss and texture changes.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Verteporfin reduces growth and stem cell traits in rat hair follicle cells by blocking the Hippo pathway.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.